DR KUNDE LIMITED 08026019 false 2023-02-01 2024-01-31 2024-01-31 The principal activity of the company is Specialists medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true true 08026019 2023-02-01 2024-01-31 08026019 2024-01-31 08026019 bus:OrdinaryShareClass1 2024-01-31 08026019 bus:OrdinaryShareClass2 2024-01-31 08026019 bus:OrdinaryShareClass3 2024-01-31 08026019 bus:OrdinaryShareClass4 2024-01-31 08026019 bus:OrdinaryShareClass5 2024-01-31 08026019 core:RetainedEarningsAccumulatedLosses 2024-01-31 08026019 core:ShareCapital 2024-01-31 08026019 core:CurrentFinancialInstruments 2024-01-31 08026019 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 08026019 bus:SmallEntities 2023-02-01 2024-01-31 08026019 bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 08026019 bus:AbridgedAccounts 2023-02-01 2024-01-31 08026019 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 08026019 bus:RegisteredOffice 2023-02-01 2024-01-31 08026019 bus:Director1 2023-02-01 2024-01-31 08026019 bus:Director2 2023-02-01 2024-01-31 08026019 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 08026019 bus:OrdinaryShareClass2 2023-02-01 2024-01-31 08026019 bus:OrdinaryShareClass3 2023-02-01 2024-01-31 08026019 bus:OrdinaryShareClass4 2023-02-01 2024-01-31 08026019 bus:OrdinaryShareClass5 2023-02-01 2024-01-31 08026019 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 08026019 bus:Agent1 2023-02-01 2024-01-31 08026019 core:MotorVehicles 2023-02-01 2024-01-31 08026019 core:OfficeEquipment 2023-02-01 2024-01-31 08026019 countries:EnglandWales 2023-02-01 2024-01-31 08026019 2022-02-01 2023-01-31 08026019 2023-01-31 08026019 bus:OrdinaryShareClass1 2023-01-31 08026019 bus:OrdinaryShareClass2 2023-01-31 08026019 bus:OrdinaryShareClass3 2023-01-31 08026019 bus:OrdinaryShareClass4 2023-01-31 08026019 bus:OrdinaryShareClass5 2023-01-31 08026019 core:RetainedEarningsAccumulatedLosses 2023-01-31 08026019 core:ShareCapital 2023-01-31 08026019 core:CurrentFinancialInstruments 2023-01-31 08026019 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08026019

DR KUNDE LIMITED

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 January 2024

 

DR KUNDE LIMITED

Contents

Company Information

1

Directors' Report

2

Accountants' Report

3

Statement of Comprehensive Income

4

Abridged Balance Sheet

5

Notes to the Unaudited Abridged Financial Statements

6 to 9

 

DR KUNDE LIMITED

Company Information

Directors

Dr Anuja Dattakumar Kunde

Mr Dattakumar Kunde

Registered office

The Long Lodge
265-269 Kingston Road
Wimbledon
London
SW19 3NW

Accountants

TAX LINK (CTA) LIMITED
Chartered Accountants & Tax Advisors
The Long Lodge 265-269 Kingston Road
Wimbledon
London
Wimbledon
SW19 3NW

 

DR KUNDE LIMITED

Directors' Report for the Year Ended 31 January 2024

The directors present their report and the abridged financial statements for the year ended 31 January 2024.

Directors of the company

The directors who held office during the year were as follows:

Dr Anuja Dattakumar Kunde

Mr Dattakumar Kunde

Principal activity

The principal activity of the company is Specialists medical practice activities.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 16 October 2024 and signed on its behalf by:
 

.........................................
Mr Dattakumar Kunde
Director

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
DR KUNDE LIMITED
for the Year Ended 31 January 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of DR KUNDE LIMITED for the year ended 31 January 2024 as set out on pages 4 to 9 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of DR KUNDE LIMITED, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of DR KUNDE LIMITED and state those matters that we have agreed to state to the Board of Directors of DR KUNDE LIMITED, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DR KUNDE LIMITED and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that DR KUNDE LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of DR KUNDE LIMITED. You consider that DR KUNDE LIMITED is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of DR KUNDE LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

TAX LINK (CTA) LIMITED
Chartered Accountants & Tax Advisors
The Long Lodge 265-269 Kingston Road
Wimbledon
London
Wimbledon
SW19 3NW

16 October 2024

 

DR KUNDE LIMITED

Statement of Comprehensive Income for the Year Ended 31 January 2024

2024
£

2023
£

Profit for the year

231,831

437,313

Total comprehensive income for the year

231,831

437,313

 

DR KUNDE LIMITED

(Registration number: 08026019)
Abridged Balance Sheet as at 31 January 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

43,873

58,497

Investments

800,000

800,000

Other financial assets

99,000

99,000

 

942,873

957,497

Current assets

 

Debtors

5

13,496

10,075

Cash at bank and in hand

 

2,684,094

2,570,548

 

2,697,590

2,580,623

Creditors: Amounts falling due within one year

(99,892)

(133,380)

Net current assets

 

2,597,698

2,447,243

Net assets

 

3,540,571

3,404,740

Capital and reserves

 

Called up share capital

6

1,300

1,300

Retained earnings

3,539,271

3,403,440

Shareholders' funds

 

3,540,571

3,404,740

For the financial year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 16 October 2024 and signed on its behalf by:
 

.........................................
Mr Dattakumar Kunde
Director

 

DR KUNDE LIMITED

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The Long Lodge
265-269 Kingston Road
Wimbledon
London
SW19 3NW
United Kingdom

These financial statements were authorised for issue by the Board on 16 October 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

DR KUNDE LIMITED

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer Equipment

25% Reducing balance

Motor Vehicles

25% Reducing balance

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

DR KUNDE LIMITED

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2023 - 1).

4

Profit before tax

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

14,625

8,822

5

Debtors

Debtors includes £Nil (2023 - £Nil) due after more than one year.

 

DR KUNDE LIMITED

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 January 2024

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

A Ordinary of £1 each

200

200

200

200

B Ordinary of £1 each

200

200

200

200

C Ordinary of £1 each

300

300

300

300

D Ordinary of £1 each

300

300

300

300

E Ordinary of £1 each

300

300

300

300

1,300

1,300

1,300

1,300